EC
NUVB icon

EcoR1 Capital’s Nuvation Bio NUVB Stock Holding History

EcoR1 Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,209,643
Closed -$44M – 68
2024
Q3 		$44M Hold
19,209,643
– – 1.51% 17
2024
Q2 		$56.1M Hold
19,209,643
– – 1.72% 16
2024
Q1 		$69.9M Hold
19,209,643
– – 1.77% 18
2023
Q4 		$29M Hold
19,209,643
– – 0.75% 26
2023
Q3 		$25.7M Buy
19,209,643
+5,313,100
+38% +$8.84M 0.87% 23
2023
Q2 		$25M Hold
13,896,543
– – 0.61% 23
2023
Q1 		$23.1M Hold
13,896,543
– – 0.74% 22
2022
Q4 		$26.7M Hold
13,896,543
– – 0.81% 25
2022
Q3 		$31.1M Hold
13,896,543
– – 0.92% 25
2022
Q2 		$45M Hold
13,896,543
– – 1.55% 19
2022
Q1 		$73.1M Hold
13,896,543
– – 2.29% 14
2021
Q4 		$118M Buy
13,896,543
+185,026
+1% +$1.7M 3.76% 8
2021
Q3 		$136M Hold
13,711,517
– – 4.74% 6
2021
Q2 		$128M Buy
13,711,517
+464,500
+4% +$5.3M 4.77% 6
2021
Q1 		$138M Buy
+13,247,017
New +$148M 6.14% 5

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

EcoR1 Capital's NUVB Position: Q4 2024 in Review

EcoR1 Capital sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 19,209,643 shares — an estimated $44M sold.

EcoR1 Capital first reported a position in NUVB in Q1 2021 and held it in 15 quarters. The position peaked at $138M in Q1 2021. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • EcoR1 Capital reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • EcoR1 Capital sold 19,209,643 Nuvation Bio shares in Q4 2024, an estimated $44M.
  • EcoR1 Capital first reported a position in Nuvation Bio in Q1 2021 and held it in 15 quarters.
  • EcoR1 Capital's Nuvation Bio position peaked at $138M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on EcoR1 Capital's 13F filing for Q4 2024, filed 14 Feb 2025.